| Aldara Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Aldara 5% | cream | topical | 100.0 gram(s) | OTC |
Posted by paulk about 1 year ago
I am in the middle of my treatment and I would like to say that it is HORRIBLE. I wish that I never took Aldara, I would rath...
Posted by surftavi over 2 years ago
4th week, I've had the flulike symptoms, the bones (upper ribs) hurt, I sleep almost the whole day. my back and hips hurt bad...
Posted by jandtkelly over 4 years ago
I am applying Aldara to my foehead 5 days a week for 6 weeks. In the 4th week, the skin under my eye and cheekbone begain to ...
Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 ... - PR Newswire (press release)
Small molecule ligands for this receptor have been identified, including topical imiquimod (Aldara(R)) which is approved for the treatment of basal cell ...
Thu Feb 28 06:05:45 -0500 2008
Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 ... - PharmaLive.com (press release)
Small molecule ligands for this receptor have been identified, including topical imiquimod (Aldara(R)) which is approved for the treatment of basal cell ...
Thu Feb 28 08:18:06 -0500 2008
Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 ... - PR Newswire (press release)
Small molecule ligands for this receptor have been identified, including topical imiquimod (Aldara(R)) which is approved for the treatment of basal cell ...
Thu Feb 28 06:05:45 -0500 2008
imiquimod - A synthetic agent with immune response modifying activity. As an immune response modifier (IRM), imiquimod stimulates cytokine production, especially interferon production, and exhibits antitumor activity, particularly against cutaneous cancers. Imiquimod's proapoptotic activity appears to be related to Bcl-2 overexpression in susceptible tumor cells. (NCI04)